| Literature DB >> 35646231 |
Jorge Cancino-López1, Patricio Zarricueta Vergara2, Bárbara Leyton Dinamarca3, Pedro Figueroa Contreras2, Luis Miño Cárcamo2, Nicolás Cartagena Ibarra3, Johana Soto-Sánchez4.
Abstract
Objective: The purpose of this study was to evaluate the effects of a telerehabilitation program for COVID-19 survivors on their functionality, aerobic capacity, upper-lower body strength and skeletal muscle mass index.Entities:
Keywords: Barthel index; COVID-19; Hand grip strength; Physical therapy; Skeletal muscle mass; Telerehabilitation
Year: 2021 PMID: 35646231 PMCID: PMC9098132 DOI: 10.5195/ijt.2021.6415
Source DB: PubMed Journal: Int J Telerehabil ISSN: 1945-2020
Modifications on Functionality and Physical Fitness at 12 and 24 Sessions
| Variables | Pre intervention | 12 sessions | 24 sessions | P1 | P2 | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| n | Mediana (p25-p75) | n | Mediana (p25-p75) | n | Mediana (p25-p75) | p value | Effect size | p value | Effect size | |
|
| ||||||||||
| Barthel Index (sc) | 27 | 95(85–95) | 26 | 100 (100–100) | 27 | 100 (100–100) | ≤0.0001* | 0.794 | ≤0.0001* | 0.849 |
|
| ||||||||||
| Short physical performance Battery (sc) | 25 | 11 (9–12) | 24 | 12 (11.5–12) | 25 | 12 (12–12) | 0.0012* | 0.646 | ≤0.0001* | 0.795 |
| 2MST (rs) | 25 | 57 (45–66) | 24 | 66 (60.5–81) | 25 | 80 (70–89) | <0.0001* | 0.875 | ≤0.0001* | 0.875 |
| Borg scale 2MST (6–20) | 25 | 13 (13–15) | 24 | 12 (13–15) | 25 | 15 (11–15) | 0.5654 | 0.124 | 0.7552 | 0.069 |
| Handgrip (kg) | 27 | 28 (19–34) | 26 | 28.5(26–38) | 27 | 32 (28–36) | ≤0.0001* | 0.743 | ≤0.0001* | 0.798 |
| Handgrip (kg)/body weight (kg) | 27 | 0.32 (0.25–0.40) | 26 | 0.36 (0.32–0.44) | 27 | 0.38 (0.34–0.44) | ≤0.0001* | 0.695 | ≤0.0001* | 0.744 |
| 1RM Dumbbell Elbow flexion (kg) | 45 | 4.7 (3.7–5.9) | 43 | 7.5 (5.8–8.5) | 45 | 8.8 (7.2–10) | ≤0.0001* | 0.793 | ≤0.0001* | 0.818 |
| 30-s chair stand (rs) | 37 | 14 (11–16) | 35 | 17 (15–19) | 37 | 20 (17–21) | ≤0.0001* | 0.833 | ≤0.0001* | 0.867 |
Note. sc: score. rs: repetitions. 2MST: 2-minute step test P1: modifications between the start of the intervention and 12 sessions. P2: modifications between the start of the intervention and 24 sessions.
: Effect size by Cohen's d.
All data was analyzed with pared Wilcoxon test.
Modifications on Anthropometrics and Body Composition at 12 and 24 Sessions
| Variables | Pre intervention | 12 sessions | 24 sessions | P1 | P2 | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| n | Mediana (p25-p75) | n | Mediana (p25-p75) | n | Mediana (p25-p75) | p value | Effect size | p value | Effect size | |
| Weight (kg) | 50 | 76.1 (64.4–93.4) | 78.1 (68.9–91.1) | 48 | 78.9 (71.5–95.2) | 0.0009* | 0.466 | ≤0.0001* | 0.625 | |
| BMI (kg/m2) | 50 | 29.71 (26.42–33.02) | 48 | 30.43 (27.26–33.21) | 50 | 30.98 (27.82–33.74) | 0.0008* | 0.474 | ≤0.0001* | 0.630 |
| Waist + (cm) | 50 | 98 (92–107) | 48 | 97.5(90.5–104) | 50 | 98 (92–106) | 0.7654 | 0.044 | 0.0500 | 0.277 |
| Waist/Height index | 50 | 0.61 (0.57–0.65) | 48 | 0.60 (0.56–0.65) | 50 | 0.61 (0.56–0.66) | 0.8486 | 0.028 | 0.0539 | 0.272 |
| Body Fat (%) | 50 | 38.15 (31.5–43.5) | 48 | 37.4 (31.35–41.35) | 50 | 36.95 (33.1–39.5) | 0.1178 | 0.227 | 0.0402* | 0.289 |
| Muscle mass (kg) | 50 | 45.95 (38.8–52.7) | 48 | 47.3 (39.4–56.75) | 50 | 48.7(42–57.2) | ≤0.0001* | 0.555 | ≤0.0001* | 0.761 |
| SMI (kg/m2) | 41 | 7.84 (7.16–8.37) | 39 | 7.9 (7.3–8.7) | 41 | 8.2 (7.8–8.8) | 0.0704 | 0.291 | ≤0.0001* | 0.697 |
Note. BMI: Body mass index. SMI= Skeletal muscle mass index. P1: modifications between the start of the intervention and 12 sessions. P2: modifications between the start of the intervention and 24 sessions.
: Effect size by Cohen's d.
All data was analyzed with pared Wilcoxon test.
Modifications Cardiovascular and Respiratory Parameters at 12 and 24 Sessions
| Variables | Pre intervention | 12 sessions | 24 sessions | P1 | P2 | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| n | Mediana (p25-p75) | n | Mediana (p25-p75) | n | Mediana (p25-p75) | p value | Effect size | p value | Effect size | |
|
| ||||||||||
| PR PS (beats/min) | 50 | 82.5 (72–90) | 48 | 77 (70.5–85.5) | 50 | 78 (71–87) | 0.0118* | 0.360 | 0.3077 | 0.146 |
| PR PTS (beats/min) | 50 | 84 (72–96) | 48 | 83.5 (76–96) | 50 | 94 (83–103) | 0.0686 | 0.263 | ≤0.0001* | 0.549 |
| SBP PS (mmHg) | 50 | 131.5 (123–150) | 48 | 132 (117.5–139) | 50 | 129 (118–139) | 0.0040* | 0.409 | 0.0022* | 0.425 |
| SBP PTS (mmHg) | 50 | 135.5 (123–148) | 48 | 138.5 (125.5–151.5) | 50 | 140.5 (126–151) | 0.5949 | 0.078 | 0.1693 | 0.195 |
| DBP PS (mmHg) | 50 | 83.5 (77–92) | 48 | 82 (75–87.5) | 50 | 79.5 (73–87) | 0.0438* | 0.290 | 0.0006* | 0.475 |
| DBP PTS (mmHg) | 49 | 82 (74–89) | 47 | 78 (73–87) | 49 | 77 (69–85) | 0.0091* | 0.376 | 0.0004* | 0.492 |
| DP PS mmHg/beat/min | 50 | 11014.5 (9300–12441) | 48 | 9662 (8881–11070) | 50 | 9988 (9009–11200) | 0.0012* | 0.456 | 0.0190* | 0.330 |
| DP PTS mmHg/beat/min | 50 | 11213 (9856–12920) | 48 | 11853.5 (9983.5–13720) | 50 | 13294 (11454–14161) | 0.0668 | 0.265 | ≤0.0001* | 0.596 |
|
| ||||||||||
| SO2 PS (%) | 50 | 96 (95–98) | 48 | 96 (95–97) | 50 | 96 (95–97) | 0.5696 | 0.829 | 0.3824 | 0.125 |
| SO2 PTS (%) | 50 | 96 (94–98) | 48 | 96.5 (96–97) | 50 | 97 (96–97) | 0.0175* | 0.341 | 0.0240* | 0.317 |
Note. PR PS: Pulse rate pre session. PR PTS: Pulse rate post session SBP PS: Systolic blood pressure pre session. SBP PTS: Systolic blood pressure post session. DBP PS: Diastolic blood pressure pre session. DBP PTS: Diastolic blood pressure post session. DP PS: double product pre session. DP PTS: double product post session. SO2 PS: Pulse oximetry pre session. SO2 PTS: Pulse oximetry post session. P1: modifications between the start of the intervention and 12 sessions. P2: modifications between the start of the intervention and 24 sessions.
: Effect size by Cohen's d.
All data was analyzed with pared Wilcoxon test.